SKI Market

A+| A| A-|

Indian Indices

Sensex

76,558.10 -938.26
( -1.21%)

Global Indices

Nasdaq

48,888.32 -274.62
(-0.56%)

Dow Jones

7,157.73 -2.07
(-0.03%)

Hang Seng

59,839.06 -698.30
(-1.15%)

Nikkei 225

10,208.73 -124.06
(-1.20%)

Forex

USD-INR

94.52 0.35
(0.37%)

EUR-INR

110.65 0.18
(0.17%)

GBP-INR

127.71 0.18
(0.14%)

JPY-INR

0.59 0.00
(0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Astal Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

512600

INE307N01014

76.88845

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

27.16

265.96

EPS(TTM)

Face Value()

Div & Yield %

2.32

Back

DE Nora India standalone net profit rises 17.99% in the September 2025 quarter

Nov 06,2025

Net profit of DE Nora India rose 17.99% to Rs 3.87 crore in the quarter ended September 2025 as against Rs 3.28 crore during the previous quarter ended September 2024. Sales rose 20.46% to Rs 21.84 crore in the quarter ended September 2025 as against Rs 18.13 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	21.84	18.13	20
OPM %	18.41	17.76	-
PBDT	5.72	4.87	17
PBT	5.20	4.45	17
NP	3.87	3.28	18

76,558.10 -938.26 ( -1.21%)

48,888.32 -274.62 (-0.56%)

7,157.73 -2.07 (-0.03%)

59,839.06 -698.30 (-1.15%)

10,208.73 -124.06 (-1.20%)

94.52 0.35 (0.37%)

110.65 0.18 (0.17%)

127.71 0.18 (0.14%)

0.59 0.00 (0.25%)